SANOFI-SYNTHELABO (INDIA) PRIVATE LIMITED

OVERVIEW - SANOFI-SYNTHELABO (INDIA) PRIVATE LIMITED

Sanofi-Synthelabo (India) Private Limited was an unlisted private company incorporated on 25 October, 2002. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital was INR 43.15 cr and the total paid-up capital was INR 33.41 cr.

Sanofi-Synthelabo (India) Private Limited's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2019. It's EBITDA has decreased by -15.10 % over the previous year. At the same time, it's book networth has increased by 9.53 %. Other performance and liquidity ratios are available here.

Description: The company manufactures and markets therapeutic solutions.

Products & Services: Desowen Cream, Desowen Lotion, Perlice Creme Rinse, Permite Cream etc
Category: Manufacturer

The current status of Sanofi-Synthelabo (India) Private Limited is - Amalgamated.

The last reported AGM (Annual General Meeting) of Sanofi-Synthelabo (India) Private Limited, per our records, was held on 27 November, 2020.

The Corporate Identification Number (CIN) of Sanofi-Synthelabo (India) Private Limited is U24230MH2002PTC137682. The registered office of Sanofi-Synthelabo (India) Private Limited was at SANOFI HOUSE, CTS NO.117-B, L&T BUSINESS PARK, SAKI VIHAR ROAD, POWAI MUMBAI Mumbai City , Maharashtra. The status of the company is now Amalgamated.

REGISTERED DETAILS - SANOFI-SYNTHELABO (INDIA) PRIVATE LIMITED

---

---

---

---

Directors - SANOFI-SYNTHELABO (INDIA) PRIVATE LIMITED

The company is no longer active. The following people were the last known directors of the company.

The company has 3 directors and 1 reported key management personnel.

The longest serving director currently on board is Rajaram Narayanan who was appointed on 01 January, 2018. Rajaram Narayanan has been on the board for more than 6 years. The most recently appointed director is Vaibhav Vinayak Karandikar, who was appointed on 02 February, 2021.

Rajaram Narayanan has the largest number of other directorships with a seat at a total of 6 companies. In total, the company is connected to 7 other companies through its directors.

NAME	DESIGNATION	APPOINTMENT DATE
RAJARAM NARAYANAN	Director	01 January, 2018	Other directorships - SANOFI ANIMAL HEALTH INDIA PRIVATE LIMITED,  GENZYME INDIA PRIVATE LIMITED,  ALIVIRA ANIMAL HEALTH LIMITED,  SEQUENT SCIENTIFIC LIMITED,  SEQUENT RESEARCH LIMITED,
PRAVEEN KHULLAR	Director	14 December, 2018	Other directorships - VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED,
VAIBHAV VINAYAK KARANDIKAR	Director	02 February, 2021	Other directorships - SANOFI INDIA LIMITED,
DEEPA RAMNIKLAL SHAH	KMP	30 March, 2017	No other directorships

NAME	DESIGNATION	APPOINTMENT DATE
RAJARAM NARAYANAN	Director	01 January, 2018	View other directorships
COMPANY NAME DESIGNATION APPOINTMENT DATE INDUSTRY SANOFI ANIMAL HEALTH INDIA PRIVATE LIMITED Director 01 January, 2018 Manufacturing (Chemicals and chemical products) GENZYME INDIA PRIVATE LIMITED Director 01 January, 2018 Electricity, Gas & Water ALIVIRA ANIMAL HEALTH LIMITED Director 11 April, 2022 Business Services SEQUENT SCIENTIFIC LIMITED Director 11 April, 2022 Community, Personal and Social Services SEQUENT RESEARCH LIMITED Director 11 April, 2022 Manufacturing (Chemicals and chemical products)
PRAVEEN KHULLAR	Director	14 December, 2018	View other directorships
COMPANY NAME DESIGNATION APPOINTMENT DATE INDUSTRY VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED Director 06 April, 2022 Research and Development
VAIBHAV VINAYAK KARANDIKAR	Director	02 February, 2021	View other directorships
COMPANY NAME DESIGNATION APPOINTMENT DATE INDUSTRY SANOFI INDIA LIMITED Director 23 February, 2021 Manufacturing (Chemicals and chemical products)
DEEPA RAMNIKLAL SHAH	KMP	30 March, 2017	No other directorships
COMPANY NAME DESIGNATION APPOINTMENT DATE INDUSTRY